By Rick Pezzullo— The U.S. Food and Drug Administration (FDA) has given emergency use authorization to an antibody cocktail created by Tarrytown-based Regeneron Pharmaceuticals, Inc. for recently diagnosed, mild to moderate COVID-19 high-risk patients. Initial doses of REGEN-COV2 will be made available to approximately 300,000 patients, with no medication out-of-pocket costs, under a U.S. government allocation program. The cocktail can also be used in pediatric patients at least 12 years of age and weighing at least 40 kg, who have received positive […]
The post Regeneron Antibody Cocktail for COVID-19 Receives FDA Emergency Use Authorization appeared first on The Hudson Independent Community News -.